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Objectives: The classification of disease activity states in rheumatoid arthritis (RA) can 
be achieved through disease activity indices, such as the Disease Activity Score in 28 
joints erythrocyte sedimentation rate (DAS28-ESR), the Simplified Disease Activity Index 
(SDAI), and the Clinical Disease Activity Index (CDAI). Subjective measurements, such as 
patient reported outcomes have been incorporated into several of these indices along-
side more objective assessments, such as increases in the ESR and C-reactive protein. 
Moreover, while they use similar criteria, different indices weight these criteria to different 
extents. Therefore, the classifications based on each evaluation may not always be the 
same. We aim to compare the performance of the three indices and their individual 
components in two different populations.
Methods: Data from Dutch and Portuguese adherent centers were extracted from the 
METEOR database, a multinational collaboration on RA. We included a total of 24,605 
visits from Dutch centers (from 5,870 patients) and 20,120 visits from Portuguese cen-
ters (from 3,185 patients). We compared the disease activity states as evaluated by 
the DAS28-ESR, CDAI, and SDAI across the two populations. In addition, we analyzed 
the individual components of each evaluation, including their respective contributions 
to the outcome, in each population.
results: We found significant differences in the disease activity states classified with the 
DAS28-ESR between the two populations. SDAI and CDAI had more congruous results. 
While the proportion of visits to Dutch and Portuguese centers that were classified as 
“in remission” was very similar between the CDAI and SDAI, the DAS28-ESR gave 
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discordant results. Dutch patients had lower ESRs, which is more heavily weighted in the 
DAS28-ESR. In addition, even though the mean physicians’ global assessment values 
did not vary significantly for Dutch vs Portuguese physicians, we found that doctors at 
Portuguese centers overall scored the physician’s global assessment lower than Dutch 
physicians for patient visits classified by disease activity state.
conclusion: While the CDAI and SDAI assigned disease activity states that were largely 
similar, the DAS28-ESR was often discordant across the two populations. Moreover, we 
found that physicians, more than patients, evaluated disease activity differently among 
the Portuguese and Dutch populations.
Keywords: rheumatoid arthritis, disease activity, patient reported outcomes, physicians’ perspective, acute phase 
reactants, Das28-esr, MeTeOr
inTrODUcTiOn
Rheumatoid arthritis (RA) is a chronic, inflammatory disease 
that can affect joints, resulting in pain and discomfort. Patient 
reported outcomes (PROs) are increasingly being included in 
clinical trials and clinical practice to evaluate pain, function, and 
quality of life. PROs have also been incorporated into several 
of the major disease activity indices alongside more objective 
assessments, such as increases in the erythrocyte sedimentation 
rate (ESR) and C-reactive protein (CRP). Specifically, the Disease 
Activity Score in 28 joints (DAS28-ESR) (1), the Simplified 
Disease Activity Index (SDAI) (2), and the Clinical Disease 
Activity Index (CDAI) (3) are the disease activity indices that 
are most frequently used in RA, which generate specific cut-off 
values that are used to classify RA as in remission or in a low, 
moderate, or high activity state (4–6).
DAS28-ESR (1) is the most commonly used evaluation in daily 
practice, as well as in clinical trials, where it has also been vali-
dated for assessment of treatment response (4, 7, 8). In contrast, 
SDAI (2) and CDAI (3) were developed later than DAS28-ESR 
(5), although the SDAI is included in the American College of 
Rheumatology (ACR)/European League Against Rheumatism 
(EULAR) remission criteria (9) and more often used in clinical 
trials. All three evaluations rely on composite scores and include 
similar individual components; however, the components are 
weighed differently in each assessment (3). In addition, the evalu-
ations incorporate both objective and subjective components, 
including both patient and physician perspectives, which are not 
always the same. As such, there is the potential for variability 
between these indices, and our previous work, along with that of 
others, has reported disagreements (10, 11). This could be con-
cerning, as physicians use the scores obtained to make decisions 
regarding proper treatment and dosing, although they also take 
into account the patient’s clinical history and perspectives, as well 
as their own professional observations.
Therefore, the primary objective of this study was to compare 
the performance of the three indices and their individual com-
ponents in two different populations. Since patient and physician 
perspectives can vary based on factors such as education and 
culture, we compared these different measures in two distinct 
populations, using the Measurement of Efficacy of Treatment in 
the Era of Rheumatology (METEOR) multinational database.
MaTerials anD MeThODs
Patients and Visits
Data from Dutch and Portuguese adherent centers were extracted 
from the METEOR database, a multinational collaboration on 
RA, from 2008 until 2013 (12). The database provides data on 
patient- and physician-reported outcome measures in RA. 
De-identified data have been longitudinally collected in the 
central database. Data collection from both countries started in 
2008 (12, 13). Currently, the tool is used worldwide and includes 
more than 50,000 patients. Data from Dutch centers were 
directly inserted in METEOR, by physicians and clinical nurses. 
Netherlands data included patients from one university hospital 
(the majority) and several other centers of secondary care from 
the western part of the Netherlands. Conversely, Portuguese 
visits were initially registered in Reuma.pt, the nationwide 
Portuguese Rheumatic Diseases Register, from the Portuguese 
Society of Rheumatology that comprises contribution from 90% 
of Portuguese rheumatology centers (academic centers, public, 
and private hospitals) (13), and then were posteriorly exported 
to METEOR. Data acquisition was made by rheumatologist or 
rheumatology nurses. All RA patients fulfilled the 1987 ACR 
criteria for the diagnosis of RA (14). Our data set contained infor-
mation from 9,055 RA patients for a total of 44,725 visits (24,605 
visits from 5,870 Dutch patients and 20,120 visits from 3,185 
Portuguese patients). Reuma.pt was approved by the Portuguese 
National Data Protection Board and the ethics committees of 
the participating hospitals. Patients provided written informed 
consent for registry participation. METEOR was approved by the 
local ethics committees and is adherent with European General 
Data Protection Regulation guidelines. All study procedures were 
in accordance with the Declaration of Helsinki. The METEOR 
tool used only de-identified data and all personal information 
was encrypted locally.
Measurements
Information was obtained about tender joint count based on 
28-joint assessment (TJC28), swollen joint count based on 28-joint 
assessment (SJC28), physician’s global assessment of RA disease 
activity on a 100 mm visual analog scale (MDGA), patient’s global 
assessment of activity on a 100 mm analog scale, ESR and CRP 
TaBle 1 | Cutoff values for different disease activity states.
index remission low Moderate high
DAS28-erythrocyte 
sedimentation rate
<2.6 ≥2.6 and ≤3.2 >3.2 and ≤5.1 >5.1
CDAI ≤2.8 >2.8 and ≤10 >10 and ≤22 >22
SDAI ≤3.3 >3.3 and ≤11 >11 and ≤26 >26
DAS, disease activity score; CDAI, clinical disease activity index; SDAI, simplified 
disease activity index.
TaBle 2 | Characteristics of patients and their visits.
Dutch Portuguese
N Patient N Patient
a. Patients’ characteristics
Patients 5,870 69.5 3,185 82.1
Female (%) 3,923 2,616
Age (years) (mean ± SD) 5,489 62.6 ± 14.7 3,180 61.7 ± 14.2
Disease duration (years) (mean ± SD) 2,278 11.8 ± 8.9 2,305 15.0 ± 10.1
Diagnosis duration (years) (mean ± SD) 2,520 10.4 ± 8.7 2,397 12.8 ± 9.0
B. Visit characteristics p-Value
Visits 24,605 35.3 ± 23.5 20,120 38.3 ± 25.4 <0.0001
PGA (mean ± SD) 21,292 14,618
MDGA (mean ± SD) 8,119 27.4 ± 20.9 10,160 27.1 ± 21.8 0.33
TJC28 (mean ± SD) 22,272 2.5 ± 3.9 17,774 4 ± 5.8 <0.0001
SJC28 (mean ± SD) 22,104 1.6 ± 2.7 17,774 2.4 ± 3.9 <0.0001
ESR (mean ± SD) 20,990 19.1 ± 17.9 16,886 26.7 ± 22.6 <0.0001
C-reactive protein (mean ± SD) (mg/l) 3,724 10.1 ± 18.7 15,539 11.6 ± 21.9 <0.0001
PGA, patient assessment of disease activity (100 mm); MDGA, physician assessment of disease activity (100 mm); TJC28, 28 tender joint count; SJC28, 28 swollen joint count; 
ESR, erythrocyte sedimentation rate (mm/h).
Chi-square and t-tests were used, as appropriate. Significance: p-value < 0.05.
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and for equality of two independent means were used to compare 
the proportions of visits and the score means, respectively, at each 
disease activity state for each index and population. Correlation 
between TJC28, SJC28, ESR, and CRP was done using Pearson 
correlation test. Missing data were not imputed.
To eliminate the effect of the number of visits per patient, we 
performed a sensitivity analyses where we analyzed a subset of 
data containing one visit per patient from each population. For 
that, we wrote a Visual Basic for Applications (VBA) script that 
computed the total number of visits for each patient and, for each 
one of them, generated a random number between one and the 
total number of visits obtained. Then, for each patient, we selected 
the visit corresponding to the randomly generated number. In 
this sample of one random visit per patient, we independently 
performed the same analyses described above for the group with 
all visits. All available visits were analyzed using Stata or R pro-
gramming. Statistical significance was determined when p-values 
were less than 0.05.
resUlTs
A total of 44,725 rheumatology visits, from 9,055 RA patients, 
were included in our analysis. Of those, 5,870 patients were 
seen in Dutch centers, accounting for 24,605 visits, and 3,185 
patients were seen in Portuguese centers, accounting for 20,120 
visits. Information on the patients and their visits is described in 
Table 2.
The individual components of the disease activity scores, 
including acute phase reactants, were significantly higher for 
the Portuguese visits, with the only exception being the MDGA, 
which did not differ between groups.
We next performed an analysis of each disease activity 
category as classified by the DAS28-ESR, the CDAI, and the 
SDAI. Table 3 presents the proportion of Dutch and Portuguese 
(mg/l). Patients’ characteristics and number of visits were also 
collected (gender, age, disease duration, and disease diagnosis). 
The three clinical activity disease indices, the DAS28-ESR, SDAI, 
and CDAI were calculated as previously described (1–3).
Disease activity Definitions
The three disease activity indices (DAS28-ESR, CDAI, and SDAI) 
and their respective validated cut-offs were used to define remis-
sion, low disease activity, moderate disease activity, and high 
disease activity as described in Table 1 (4–7).
For remission definition, the 2011 ACR/EULAR Boolean 
remission criteria were also applied in this study. In the 2011 
ACR/EULAR Boolean remission criteria, all TJC28, SJC28, CRP 
(mg/dl), and PGAvalues should be ≤1 (9).
statistical analysis
The demographic and clinical characteristics of the two popu-
lations were compared using chi-squared tests and t-tests, 
respectively, for discrete and continuous variables. DAS28-ESR, 
CDAI, and SDAI scores were calculated and at each visit the 
disease activity state was classified according to previously 
established cutoffs (4–6). We calculated the relative contribution 
of the individual components of DAS28-ESR, CDAI, and SDAI 
scores. Descriptive statistics for the RA core set measures were 
calculated. Z-tests for equality of two independent proportions 
TaBle 4 | The mean scores for the individual components of each disease activity evaluation, according to disease activity category.
Dutch visits Portuguese visits
remission low Moderate high remission low Moderate high
a. Das28-esr
PGA 20.5 ± 16.7 32.3 ± 18.2 46.3 ± 19.9 68.0 ± 17.1 18.2 ± 18.0 30.0 ± 19.0 43.2 ± 20.7 64.6 ± 19.9
TJC28 0.4 ± 0.8 1.2 ± 1.6 3.5 ± 3.2 10.2 ± 5.7 0.3 ± 0.8 0.9 ± 1.5 3.7 ± 3.5 12.8 ± 6.8
SJC28 0.3 ± 0.9 0.8 ± 1.4 2.1 ± 2.4 6.4 ± 4.5 0.3 ± 0.8 0.7 ± 1.4 2.1 ± 2.6 7.2 ± 5.4
ESR 9.1 ± 7.0 18.9 ± 13.9 25.1 ± 17.9 43.6 ± 25.8 11.2 ± 7.0 22.6 ± 14.6 29.8 ± 20.5 46.6 ± 27.8
DAS28-ESR 1.8 ± 0.6 2.9 ± 0.2 4.0 ± 0.5 5.8 ± 0.6 1.9 ± 0.5 2.9 ± 0.2 4.1 ± 0.5 6.1 ± 0.8
B. cDai
PGA 6.5 ± 6.0 30.2 ± 14.9 52.7 ± 17.7 68.6 ± 16.6 6.0 ± 6.7 31.6 ± 17.0 50.4 ± 19.0 65.3 ± 19.9
MDGA 5.2 ± 4.7 18.8 ± 10.1 40.2 ± 15.3 61.7 ± 16.2 3.3 ± 4.3 16.0 ± 10.2 35.8 ± 14.8 56.2 ± 18.1
TJC28 0.1 ± 0.3 0.8 ± 1.1 3.4 ± 2.4 11.1 ± 6.0 0.1 ± 0.3 0.9 ± 1.2 4.0 ± 2.8 13.9 ± 6.5
SJC28 0.0 ± 0.2 0.5 ± 0.9 2.2 ± 2.1 6.7 ± 4.9 0.1 ± 0.3 0.6 ± 1.0 2.6 ± 2.3 8.0 ± 5.3
CDAI 1.3 ± 0.9 6.2 ± 2.1 14.9 ± 3.3 30.8 ± 8.2 1.1 ± 0.9 6.3 ± 2.1 15.2 ± 3.4 34.0 ± 10.0
c. sDai
PGA 5.5 ± 6.2 30.3 ± 15.8 54.5 ± 18.0 68.3 ± 17.8 7.0 ± 7.6 31.6 ± 17.1 50.8 ± 19.3 66.2 ± 19.8
MDGA 4.8 ± 5.0 20.6 ± 11.6 45.9 ± 16.9 65.3 ± 16.1 3.7 ± 4.6 15.8 ± 10.2 36.0 ± 15.0 57.8 ± 17.9
TJC28 0.1 ± 0.4 0.9 ± 1.2 4.3 ± 3.2 13.4 ± 6.9 0.1 ± 0.3 0.9 ± 1.2 4.3 ± 3.3 14.5 ± 6.6
SJC28 0.1 ± 0.2 0.5 ± 0.9 2.0 ± 2.6 7.0 ± 5.8 0.1 ± 0.3 0.6 ± 1.1 2.7 ± 2.4 8.3 ± 5.4
CRP 3.7 ± 3.8 5.8 ± 6.7 9.0 ± 11.4 23.8 ± 37.7 4.1 ± 4.5 6.6 ± 9.2 13.3 ± 19.9 27.9 ± 39.5
SDAI 1.6 ± 1.0 7.1 ± 2.2 17.3 ± 4.1 36.1 ± 9.6 1.7 ± 1.0 7.0 ± 2.2 17.1 ± 4.2 38.0 ± 10.2
PGA, patient assessment of disease activity (100 mm); MDGA, physician assessment of disease activity (100 mm); TJC28, 28 tender joint count; SJC28, 28 swollen joint count; 
CRP, C-reactive protein (mg/l); ESR, erythrocyte sedimentation rate (mm/h); DAS28-ESR, disease activity score evaluating 28 joints; CDAI, clinical disease activity index; SDAI, 
simplified disease activity index.
All data are represented as the mean ± SD.
TaBle 3 | The number and percentage of visits in each population according to 
disease activity state and corresponding z-tests for equality of two independent 
proportions.
Dutch  
visits
Portuguese 
visits
N % N % z p-Value
DAS28-ESR 
remission
7,713 39.17 3,890 27.77 12.56 <0.0001
DAS28-ESR low 3,583 18.20 2,157 15.40 2.77 0.005
DAS28-ESR 
moderate
6,783 34.45 5,354 38.22 −4.28 <0.0001
DAS28-ESR high 1,610 8.18 2,608 18.62 −10.20 <0.0001
CDAI remission 1,298 16.93 1,489 14.83 1.51 0.13
CDAI low 3,266 42.59 3,874 38.58 3.44 0.0006
CDAI moderate 2,262 29.50 2,833 28.21 1.00 0.32
CDAI high 843 10.99 1,846 18.38 −5.26 <0.0001
SDAI remission 292 16.88 1,433 15.42 0.61 0.54
SDAI low 543 31.39 3,508 37.75 −2.96 0.003
SDAI moderate 636 36.76 2,890 31.10 2.70 0.007
SDAI high 259 14.97 1,461 15.72 −0.31 0.76
ACR/European 
League against 
rheumatism 
remission
393 13.04 1,622 12.27 0.41 0.68
N, number of visits; z, z-test for equality of two independent proportions.
DAS28-ESR, disease activity score in 28 joints; CDAI, clinical disease activity index; 
SDAI, simplified disease activity index.
z > 0 when the proportion in Dutch group is higher than in Portuguese group.
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different between the two populations. Specifically, significantly 
more visits to Portuguese centers involved patients classified as 
moderate or high disease activity by the DAS28-ESR than the 
Dutch centers. In comparison, the CDAI and SDAI results had 
a more homogenous distribution across visits. In addition, for 
the remission category, no significant differences were detected 
between the two populations according to the CDAI, SDAI, and 
ACR/EULAR 2011 remission criteria (9).
We also compared the individual components of the DAS28-
ESR, CDAI, and SDAI between the two populations at each 
disease activity state (Tables  4 and 5). With the exception of 
the high disease activity category, we found ESR to be the indi-
vidual parameter that differed the most between the Dutch and 
Portuguese visits. In addition, even though the mean physician’s 
global assessment values did not vary significantly for Dutch 
vs Portuguese physicians, we found that doctors at Portuguese 
centers overall scored the physician’s global assessment lower 
than Dutch physicians for patient visits with same disease activ-
ity state.
In Dutch centers, SJC28 was positively correlated with TJC28 
(r = 0.56; p < 0.001), with ESR (r = 0.23; p < 0.001) and with CRP 
(r = 0.32; p < 0.001). TJC28 was also positively correlated with ESR 
(r = 0.15; p < 0.001) and CRP (r = 0.17; p < 0.001). The same find-
ings were found for the visits made in Portuguese centers, where 
SJC28 were positively correlated with TJC28 (r = 0.66; p < 0.001), 
ESR (r = 0.28; p < 0.001), and CRP (r = 0.25; p < 0.001). TJC28 
was also positively correlated with ESR (r = 0.21; p < 0.001) and 
CRP (r = 0.19; p < 0.001). For both countries, these correlations 
are weak with the exception of the correlation between SJC28 and 
TJC28 where a moderate/good correlation was found.
visits in which the patient was classified into each disease activity 
category. We found that the proportion of patient visits in each 
disease category as classified by the DAS28-ESR was significantly 
TaBle 5 | Comparison of the mean scores from the individual components of each disease activity evaluation between the Dutch and Portuguese populations.
remission low Moderate high
z p-Value z p-Value z p-Value z p-Value
a. Das28-esr
PGA 6.73 <0.0001 4.49 <0.0001 8.39 <0.0001 5.82 <0.0001
TJC28 6.24 <0.0001 6.84 <0.0001 −2.61 0.0090 −13.61 <0.0001
SJC28 3.65 0.0003 1.94 0.0520 −0.88 0.3791 −5.32 <0.0001
ESR −14.33 <0.0001 −9.59 <0.0001 −13.41 <0.0001 −3.57 0.0004
DAS28-ESR −7.34 <0.0001 −0.49 0.6245 −7.94 <0.0001 −10.44 <0.0001
B. cDai
PGA 1.99 0.0465 −3.71 0.0002 4.64 <0.0001 4.40 <0.0001
MDGA 10.63 <0.0001 11.84 <0.0001 10.4 <0.0001 7.75 <0.0001
TJC28 1.37 0.1713 −3.38 0.0007 −7.95 <0.0001 −11.06 <0.0001
SJC28 −4.59 <0.0001 −4.26 <0.0001 −6.11 <0.0001 −5.99 <0.0001
CDAI 5.87 <0.0001 −0.85 0.3949 −2.85 0.0044 −8.76 <0.0001
c. sDai
PGA −3.56 0.0004 −1.77 0.0763 4.52 <0.0001 1.67 0.0955
MDGA 3.66 0.0003 9.13 <0.0001 13.58 <0.0001 6.79 <0.0001
TJC28 1.90 0.0575 0.06 0.9515 −0.31 0.7548 −2.37 0.0179
SJC28 −1.91 0.0555 −3.39 0.0007 −5.78 <0.0001 −3.52 0.0004
CRP −1.54 0.1232 −2.4 0.0162 −7.27 <0.0001 −1.62 0.1050
SDAI −0.86 0.3912 1.31 0.19 1.22 0.2233 −2.94 0.0033
Visits, number of visits (%); PGA, patient assessment of disease activity (100 mm); TJC28, 28 tender joint count; SJC28, 28 swollen joint count; MDGA, physician assessment 
of disease activity (100 mm); CRP, C-reactive protein (mg/l); ESR, erythrocyte sedimentation rate (mm/h); DAS28-ESR, disease activity score evaluating 28 joints; CDAI, clinical 
disease activity index; SDAI, simplified disease activity index; z, z-test for equality of two independent means (z > 0 if the mean for the Dutch population was higher than that of the 
Portuguese).
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The relative contribution of each individual component 
(independent of the weight of the variable, given by the stand-
ard calculation formula) was also determined. For the CDAI, 
we found that the contribution of global assessments of disease 
activity was decreased, and the contribution of joint counts 
was increased, in the high disease activity states compared to 
remission. We identified similar results with the SDAI; however, 
we also found that CRP (not included in the CDAI) had less 
of a contribution in high disease states compared to remission. 
With respect to the DAS28-ESR, the relative contribution of the 
individual components was very similar across populations and 
across all disease activity categories. Finally, the relative contri-
bution of the PGA was higher for visits in which the CDAI and 
SDAI classified the patient as in remission than when remission 
was determined by DAS28-ESR. As such, higher PGA values 
were reported for visits in which patients were determined to be 
in remission by the DAS28-ESR than by the CDAI/SDAI, and 
less than 50% of “DAS28-ESR remission” visits were also in the 
CDAI or SDAI remission category.
To eliminate the effect of the number of visits per patient, we 
performed a sensitivity analysis where one visit was selected at 
random to analyze per patient. For this, we found that while the 
sample size was reduced, the results were generally unchanged 
(Tables 6 and 7).
DiscUssiOn
Here, we have compared the DAS28-ESR, CDAI and SDAI 
indices in clinical practice in both Portuguese and Dutch popu-
lations using a large sample of RA patients retrieved from the 
multinational METEOR database. These populations had differ-
ent sociodemographic characteristics (the Portuguese popula-
tion included more women and had a longer disease duration); 
however, our primary aim was to compare the performance of the 
three indices and their individual components, not the disease 
activity within each population. Nevertheless, we found differ-
ences in disease activity between Portuguese and Dutch popula-
tions, with the exception for MDGA values.
We observed that use of the DAS28-ESR to characterize 
patients’ disease activity states resulted in larger differences in 
the proportion of patients assigned to each state between the 
Dutch and Portuguese populations, compared to the CDAI and 
SDAI assessments. We also found that ESR which is weighted 
more substantially in the DAS28-ESR than the other evaluations, 
differed the most between the two populations, which might 
explain the level of disagreement observed between the Dutch 
and Portuguese populations when using this assessment (15). The 
higher levels of ESR in RA patients seen in Portuguese centers 
may be explained by the higher prevalence of obesity found in 
Portuguese population as compared to the Dutch (16). However, 
in our study, we did not have data to confirm this hypothesis. 
For the CDAI and SDAI, PGA was the most influential measure 
across all disease activity states, except for high disease activity. 
This could be due to the subjective nature of the PGA, as patients’ 
assessments of disease activity may vary depending on their 
individual characteristics, such as personality, sociodemographic 
factors, or culture (7, 17–20). Taken together, our results suggest 
that, by weighting the individual components of the assessment 
differently, the DAS28-ESR and the CDAI/SDAI may result in 
different classifications of RA disease activity.
TaBle 6 | Patients’ characteristics and disease activity assessment using a randomly selected visit per patient.
Dutch Portuguese
N Patient N Patient z p-Value
characteristics
Female (%) 5,870 69.5 3,185 82.1 <0.0001
3,923 2,616
Age (years) (mean ± SD) 5,489 62.6 ± 14.7 3,180 61.7 ± 14.2 0.003
Disease duration (years) (mean ± SD) 2,278 11.8 ± 8.9 2,305 15.0 ± 10.1 <0.0001
Diagnosis duration (years) (mean ± SD) 2,520 10.4 ± 8.7 2,397 12.8 ± 9.0 <0.0001
Disease activity assessment
PGA (mean ± SD) 4,953 35.1 ± 23.7 2,134 38.5 ± 25.5 <0.0001
MDGA (mean ± SD) 1,939 28.3 ± 22.0 1,472 26.6 ± 21.1 0.023
TJC28 (mean ± SD) 5,327 2.6 ± 4.2 2,509 3.9 ± 5.8 <0.0001
SJC28 (mean ± SD) 5,272 1.6 ± 2.9 2,509 2.2 ± 3.7 <0.0001
ESR (mean ± SD) 4,874 18.9 ± 17.4 2,364 26.9 ± 22.7 <0.0001
CRP (mg/l) (mean ± SD) 961 9.2 ± 15.3 2,212 12.5 ± 22.7 <0.0001
Disease activity scores
DAS28 Remission (%) 1,804 39.68% 564 27.78% 5.38 <0.0001
DAS28 Low (%) 847 18.63% 310 15.27% 1.38 0.1688
DAS28 moderate (%) 1,522 33.48% 790 38.92% −2.57 0.0102
DAS28 high (%) 373 8.21% 366 18.03% −3.99 0.0001
CDAI remission (%) 332 18.15% 205 14.25% 1.21 0.2266
CDAI Low (%) 721 39.42% 555 38.57% 0.31 0.757
CDAI moderate (%) 538 29.41% 439 30.51% −0.37 0.711
CDAI high (%) 238 13.01% 240 16.68% −1.13 0.259
SDAI remission (%) 70 13.21% 190 14.21% −0.21 0.8335
SDAI low (%) 157 29.62% 510 38.15% −2.01 0.044
SDAI Moderate (%) 205 38.68% 440 32.91% 1.42 0.1566
SDAI high (%) 98 18.49% 197 14.73% −3.96 0.0001
ACR/European League Against  
Rheumatism Remission (%)
77 10.03% 219 11.43% −1.08 0.282
PGA, patient assessment of disease activity (100 mm); MDGA, Physician assessment of disease activity (100 mm); TJC28, 28 tender joint count; SJC28, 28 swollen joint count; 
ESR, erythrocyte sedimentation rate (mm/h); CRP, C-reactive protein (mg/l); DAS28, disease activity score evaluating 28 joints; CDAI, clinical disease activity index; SDAI, simplified 
disease activity index.
Chi-square and t-tests were used as appropriate. Significant p-value < 0.05.
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In addition, there is an ongoing discussion about the appropri-
ateness of cut-off values for therapy response criteria, as debated 
in a paper by González-Álvaro and colleagues (21). Remission 
assessed by both the CDAI and the SDAI were found to be more 
stringent than the DAS28-ESR score, but less so than the ACR/
EULAR remission criteria. This is in agreement with previous 
findings (11, 22) and suggests that the DAS28-ESR value of 2.6 
may not be the most appropriate remission cut-off point (23). 
Moreover, in our study, the mean PGA value for patients with 
a DAS28-ESR score of less 2.6 is approximately twice than the 
PGA value for patients classified in remission according to the 
ACR/EULAR Boolean criteria. The low impact that a high PGA 
has in the DAS28-ESR seemed to be the primary reason for the 
significantly higher percentage of DAS28-ESR visits classified 
as in remission in the Dutch clinics, compared to Portuguese. 
Conversely, other reports have investigated potential problems 
stemming from the inclusion of the PGA as a component of the 
ACR/EULAR remission criteria (24), and these same issues likely 
extend to the CDAI and SDAI, due to the heavy contribution of 
the PGA in these indices.
Another interesting observation of this study was that the 
Portuguese MDGA was lower than that of the Dutch, regard-
less of disease activity state, and was usually discordant from 
ESR and joint counts. This surprising result was also found in 
the Quantitative Standard Monitoring of Patients with RA 
(QUEST-RA) registry that included data from 30 countries, 
where significant intercenter variation for MDGA and ESR was 
present (25).
There are some limitations to our analysis that must be 
considered when interpreting our results. METEOR is a large 
multinational database that gathers information on daily clinical 
practice, allowing for comparisons across different RA popula-
tions. However, there were missing values for some variables, 
namely for CRP, patients’ therapies and MDGA (in particular in 
Dutch population), which limited our analysis. In addition, some 
relevant variables were not included in the METEOR database, 
such as comorbidities, body mass index and level of education. 
Therefore, we were unable to include an assessment of these 
factors.
Historically, disease activity states were defined based on the 
physician’s decision and the drugs that were prescribed (26). 
However, now physicians rely on evaluations of disease activ-
ity states to decide the appropriate treatment and management 
strategies (27). Therefore, an understanding of the disease activ-
ity indices used in clinical practice is critical and may result in 
novel insights that can be used to develop new evaluations and/
or improve the existing composite indices, such as by establish-
ing new disease activity cutoffs that may be more appropriate 
TaBle 7 | Comparison of the mean of the components of the disease activity indices within each disease activity state between Dutch and Portuguese populations 
using one randomly selected visit per patient.
remission low Moderate high
z p-Value z p-Value z p-Value z p-Value
a. Das28-esr
PGA 1.26 0.2079 0.51 0.6096 3.29 0.001 3.29 0.001
TJC28 4.1 <0.0001 3.33 0.0009 −0.39 0.6988 −3.08 0.0021
SJC28 1.68 0.0932 1.58 0.1151 1.65 0.099 0.49 0.6267
ESR −5.85 <0.0001 −3.54 0.0004 −5.65 <0.0001 −2.26 0.0241
DAS28-ESR −3.36 0.0008 −0.03 0.9799 −2.73 0.0064 −2.09 0.0364
B. cDai
PGA −0.51 0.6132 −3.64 0.0003 2.18 0.0296 1.31 0.19
MDGA 3.75 0.0002 4.76 <0.0001 6.57 <0.0001 3.77 0.0002
TJC28 0.94 0.3449 −0.37 0.7124 −4.46 <0.0001 −3.93 0.0001
SJC28 −2.58 0.0098 −0.69 0.4895 −1.74 0.0811 −1.21 0.2262
CDAI 0.96 0.339 −1.02 0.3081 −0.54 0.5865 −2.56 0.0105
c. sDai
PGA −2.37 0.0178 −2.73 0.0062 1.27 0.2042 0.59 0.5526
MDGA 1.79 0.0739 5.62 <0.0001 9.13 <0.0001 3.1 0.0019
TJC28 0.93 0.3516 1.38 0.1677 0.24 0.808 −0.05 0.9585
SJC28 −0.97 0.3312 0.1 0.9224 −0.6 0.5506 0.26 0.7943
CRP −1.42 0.157 −2.27 0.0234 −4.62 <0.0001 −2.8 0.0051
SDAI −1.14 0.2532 1.03 0.3012 2.4 0.0166 −0.23 0.8171
Visits, number of visits (%); PGA, patient assessment of disease activity (100 mm); TJC28, 28 tender joint count; SJC28, 28 swollen joint count; MDGA, physician assessment of 
disease activity (100 mm); CRP, C-reactive protein (mg/l); ESR, erythrocyte sedimentation rate (mm/h); DAS28-ESR, disease activity score evaluating 28 joints; CDAI, clinical disease 
activity index; SDAI, simplified disease activity index; z, z-test for equality of two independent means (z > 0 if the mean for Dutch group is higher than for Portuguese group).
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for different populations. Here, we report that the DAS28-ESR 
and the CDAI/SDAI weight their components differently, some-
times resulting in discordant assessments of RA disease activity. 
Therefore, these indices should not be used interchangeably. 
In addition, these tests incorporate subjective assessments as 
well as objective measurement, such as PROs and MDGA, which 
may be influenced by cultural and educational backgrounds. 
Moreover, a physician’s evaluation may differ from the patient’s 
perspective and, as was observed in this study, may also differ 
from objective assessments such as swollen joint counts. Since 
the concept of “treat-to-target” depends on well-defined targets, 
it is necessary to revise the targets in RA and achieve a standard-
ized and consistent evaluation method before this concept can 
be applied successfully.
cOnclUsiOn
Here, we used the METEOR multinational database to analyze 
data from a total of 24,605 RA visits to Dutch and Portuguese 
clinics. We compared the outcomes of three methods to assess 
RA disease activity states; specifically, the DAS28-ESR, the 
CDAI, and the SDAI. We found that the percentage of Dutch 
and Portuguese visits classified as “in remission” was very similar 
when using the CDAI, the SDAI and the ACR/EULAR remission 
criteria. However, use of the DAS28-ESR resulted in a significantly 
higher proportion of remission classifications at Dutch clinics. In 
addition, we found that Portuguese physicians tended to classify 
patients into lower disease activity states than Dutch physicians.
Taken together, our results indicate that the DAS28-ESR and 
the CDAI/SDAI weights their individual components differently, 
which sometimes caused discordant assessments of RA disease 
activity. Based on our findings, a more consistent and standard-
ized approach for classifying RA disease activity may be neces-
sary, and the evaluations used may need to be adapted to better 
suit differences between individual populations.
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